Genesis Healthcare, Inc. (GEN): Price and Financial Metrics
Genesis Healthcare, Inc. (GEN)
Today's Latest Price: $0.49 USD
Updated Oct 22 7:00pm
Add GEN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 70 in Medical - Services
See all "A" rated Strong Buy stocks
GEN Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for GEN is -5.71 -- better than merely 2.51% of US stocks.
- With a price/earnings ratio of 1.75, Genesis Healthcare Inc P/E ratio is greater than that of about just 1.28% of stocks in our set with positive earnings.
- With a price/sales ratio of 0.02, Genesis Healthcare Inc has a higher such ratio than just 0.57% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to Genesis Healthcare Inc, a group of peers worth examining would be TUP, CYH, STG, MIK, and LTRE.
- Visit GEN's SEC page to see the company's official filings. To visit the company's web site, go to www.genesishcc.com.
GEN Stock Price Chart Interactive Chart >
GEN Price/Volume Stats
| Current price | $0.49 | 52-week high | $1.86 |
| Prev. close | $0.49 | 52-week low | $0.48 |
| Day low | $0.48 | Volume | 752,998 |
| Day high | $0.50 | Avg. volume | 876,249 |
| 50-day MA | $0.60 | Dividend yield | N/A |
| 200-day MA | $0.93 | Market Cap | 81.43M |
Genesis Healthcare, Inc. (GEN) Company Bio
Genesis Healthcare provides post-acute care services through a network of skilled nursing centers and assisted/senior living communities in the United States. It operates through three segments: Long-Term Care Services, Therapy Services, and Hospice and Home Health Services. The company was founded in 2003 and is based in Kennett Square, Pennsylvania.
GEN Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $0.49 | $140.6 | 28020% |
We started the process of determining a valid price forecast for Genesis Healthcare Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Genesis Healthcare Inc ranked in the 98th percentile in terms of potential gain offered. Our DCF model suggests the stock is undervalued by 28157.5%; returns of such proportions should be viewed with some skepticism, though. In terms of the factors that were most noteworthy in this DCF analysis for GEN, they are:
- 1% of the company's capital comes from equity, which is greater than just 0.97% of stocks in our cash flow based forecasting set.
- The business' balance sheet suggests that 99% of the company's capital is sourced from debt; this is greater than 98.99% of the free cash flow producing stocks we're observing.
- The weighted average cost of capital for the company is 12. This value is greater than 85.78% stocks in the Healthcare sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 27468% |
| 1% | 27744% |
| 2% | 28020% |
| 3% | 28295% |
| 4% | 28571% |
| 5% | 28847% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as GEN, try KMDA, VRTX, THC, ASNB, and AMEH.
Loading social stream, please wait...